{"filing":{"accession_number":"0001493152-26-028614","cik":"0001971532","ticker":"TELO","company_name":"Telomir Pharmaceuticals, Inc.","form":"8-K","filing_date":"2026-06-15","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1971532/000149315226028614/form8-k.htm"},"events":[{"id":10914,"run_id":9574,"accession_number":"0001493152-26-028614","anchor_item_number":null,"event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.65,"summary":"The filing discloses a peer-reviewed publication of preclinical data for Telomir-Zn in a diabetes model, announced via press release on June 15, 2026. While this represents positive scientific validation for the company's lead clinical program (which has IND clearance), it does not fit cleanly into the standard 8-K event taxonomy. The disclosure is material to investors as it provides evidence supporting the mechanism of action and scientific foundation of the company's pipeline, but it is neither an earnings release, executive change, M\u0026A activity, nor any other specifically enumerated event type.","company_name":"Telomir Pharmaceuticals, Inc.","ticker":"TELO","filing_date":"2026-06-15","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":7351,"accession_number":"0001493152-26-028614","item_number":null,"item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.65,"reasoning":"The filing discloses a peer-reviewed publication of preclinical data for Telomir-Zn in a diabetes model, announced via press release on June 15, 2026. While this represents positive scientific validation for the company's lead clinical program (which has IND clearance), it does not fit cleanly into the standard 8-K event taxonomy. The disclosure is material to investors as it provides evidence supporting the mechanism of action and scientific foundation of the company's pipeline, but it is neither an earnings release, executive change, M\u0026A activity, nor any other specifically enumerated event type.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-15T12:02:22.336358+00:00","company_name":"Telomir Pharmaceuticals, Inc.","ticker":"TELO","filing_date":"2026-06-15"}]}